Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.755
Bid: 4.71
Ask: 4.80
Change: 0.17 (3.71%)
Spread: 0.09 (1.911%)
Open: 4.50
High: 4.765
Low: 4.50
Prev. Close: 4.585
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Bipartisan Senate legislation

11 Aug 2021 07:00

RNS Number : 2747I
Seeing Machines Limited
11 August 2021
 

 

RNS Reach

 

11 August 2021

 

Seeing Machines Limited

 

Bipartisan Senate legislation includes lifesaving automotive technology provisions

 

New agreement would require Driver Monitoring Systems to stop distracted and drunk driving

 

Canberra, Australia - Today the U.S. Senate passed a bipartisan infrastructure agreement which contains key provisions to improve automotive safety. Specifically, the legislation includes the SAFE Act, introduced by Senators Markey, Blumenthal, and Klobuchar, which would require Driver Monitoring Systems (DMS) to detect distracted driving.

 

In addition, the legislation includes the RIDE Act, which was sponsored by Senators Rick Scott and Ben Ray Lujan which would require new cars to use advanced drunk driving technology to stop impaired driving.

 

"DMS is on the road today in systems like General Motor's Super Cruise™ and can tell whether the driver is engaged in the driving task or is distracted," said Seeing Machines CEO Paul McGlone. "If the driver is distracted, driver monitoring systems have the ability to warn the driver and save lives."

 

The safety provisions would require the National Highway Traffic Administration (NHTSA) to carefully research DMS systems and begin the rulemaking process to regulate this technology. 

 

This legislation comes at a critical time in the United States. Early estimates from NHTSA point to a 9% increase in traffic deaths in 2020. In 2019, 3,142 people were killed due to distracted driving, 10,142 people died by alcohol impaired driving, and 697 people were killed by drowsy driving. DMS has the potential to reduce or eliminate all of these crashes. 

 

"Seeing Machines is pleased to see this progress on automotive safety," said McGlone. "We look forward to continuing to work with the U.S. Congress and NHTSA to ensure these technologies are available to all drivers and save the maximum number of lives."

 

 

 

Media enquiries:

 

Seeing Machines Limited

+61 2 6103 4700

Paul McGlone - CEO

Sophie Nicoll - Corporate Communications

 

 

Lionsgate Communications (Media Enquiries)

Jonathan Charles

+44 7791 892509

 

 

 

About Seeing Machines (LSE: SEE), a global company founded in 2000 and headquartered in Australia, is an industry leader in vision-based monitoring technology that enable machines to see, understand and assist people. Seeing Machines' technology portfolio of AI algorithms, embedded processing and optics, power products that need to deliver reliable real-time understanding of vehicle operators. The technology spans the critical measurement of where a driver is looking, through to classification of their cognitive state as it applies to accident risk. Reliable "driver state" measurement is the end-goal of Driver Monitoring Systems (DMS) technology. Seeing Machines develops DMS technology to drive safety for Automotive, Commercial Fleet, Off-road and Aviation. The company has offices in Australia, USA, Europe and Asia, and supplies technology solutions and services to industry leaders in each market vertical.

 

www.seeingmachines.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAGPUACRUPGUAG
Date   Source Headline
16th Aug 201811:09 amRNSHolding(s) in Company
15th Aug 20189:41 amRNSIssue of Shares for Vested Performance Rights
9th Aug 20187:00 amRNSSeeing Machines leads pilot training collaboration
3rd Aug 20187:00 amRNSYear end trading update
27th Jul 20187:00 amRNSOEM Design Award
16th Jul 20187:00 amRNSBoard changes
5th Jul 20187:00 amRNSUS Fleet (Guardian) Contract
28th Jun 20181:27 pmRNSHolding(s) in Company
15th Jun 201810:43 amRNSKey Staff Recognised
7th Jun 201811:05 amRNSSecond Price Monitoring Extn
7th Jun 201811:00 amRNSPrice Monitoring Extension
5th Jun 201811:05 amRNSSecond Price Monitoring Extn
5th Jun 201811:00 amRNSPrice Monitoring Extension
4th Jun 20187:00 amRNSAutomotive design win with US OEM for FOVIO chip
21st May 20187:00 amRNSBusiness Outlook Update
18th May 201810:14 amRNSEuropean Commission Agenda Affirms SEE Tech
17th May 20184:40 pmRNSSecond Price Monitoring Extn
17th May 20184:35 pmRNSPrice Monitoring Extension
16th May 20187:00 amRNSAustralian Distributor Expands Guardian Commitment
9th May 20184:40 pmRNSSecond Price Monitoring Extn
9th May 20184:35 pmRNSPrice Monitoring Extension
26th Apr 20187:08 amRNSAutomotive Design Award with Premium German OEM
12th Apr 20187:00 amRNSChange of Adviser
12th Mar 20187:00 amRNSHalf Year Results to 31 December 2017
9th Mar 20187:52 amRNSStatement regarding Press Speculation
28th Feb 20187:00 amRNSNotice of Results & Investor Events
22nd Feb 20188:13 amRNSHolding(s) in Company
22nd Feb 20188:00 amRNSBlock Listing Cancellation
21st Feb 20189:00 amRNSDirectorate Change Update
8th Feb 20187:00 amRNSTrading Update & Fleet, Rail and Off-Road Update
29th Jan 20187:00 amRNSDirectorate Change
23rd Jan 201810:54 amRNSHolding(s) in Company
16th Jan 20189:22 amRNSResult of Offer and Total Voting Rights
9th Jan 201810:44 amRNSHolding(s) in Company
8th Jan 20189:23 amRNSHolding(s) in Company
3rd Jan 20188:44 amRNSResult of General Meeting and Total Voting Rights
22nd Dec 20177:00 amRNSBlock Listing Return and Total Voting Rights
5th Dec 20173:57 pmRNSSuccessful Placing and Subscriptions to raise £35m
4th Dec 20175:33 pmRNSProposed Accelerated Bookbuild
30th Nov 20177:00 amRNSDubai Distributor Wins Guardian Contracts in 2017
17th Nov 20177:01 amRNSResult of AGM
17th Nov 20177:00 amRNSAGM Statement
2nd Nov 201710:02 amRNSIssue of Shares to Directors and Staff & TVR
30th Oct 20177:00 amRNSNew DMS Program Award
25th Oct 20179:00 amRNSHolding(s) in Company
25th Oct 20177:00 amRNSEmirates and Seeing Machines Collaboration
24th Oct 20177:00 amRNSEuro NCAP and NTSB - Driver Monitoring Systems
23rd Oct 20177:00 amRNSNotice of AGM
17th Oct 201712:40 pmRNSBusiness Outlook Update
10th Oct 20179:56 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.